ClinicalTrialsFinder

Japanese Encephalitis Clinical Trials in Melbourne

1 recruitingMelbourne, Australia

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults

Japanese Encephalitis Virus Disease
SK Bioscience Co., Ltd.402 enrolled3 locationsNCT06680128